Latest Articles

Primary peritoneal clear cell carcinoma with metastasis mimicking ovarian carcinoma: a case report and literature review.

Primary peritoneal clear cell carcinoma (PPCCC) is an exceptionally rare malignancy that closely resembles gynecologic epithelial cancers clinically and histologically. Its pathogenesis is poorly understood, with possible origins from Müllerian …

Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer - Targeted Oncology

Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer Targeted Oncology

How Sitting For Long Hours At Desk Job Leads To Silent Cancer Risk No One Talks About; Know From Doctor - The Daily Jagran

How Sitting For Long Hours At Desk Job Leads To Silent Cancer Risk No One Talks About; Know From Doctor The Daily Jagran

Mum who first felt pain just after partner died diagnosed with cancer a year on - The Mirror

Mum who first felt pain just after partner died diagnosed with cancer a year on The Mirror

Shared Decision Making among Patients with Chronic Conditions in France: A Cross-Sectional Survey in the ComPaRe E-Cohort.

BackgroundShared decision making (SDM) is a cornerstone of patient-centered care; however, little information is available on how SDM is practiced in routine care. We aimed to assess the level of …

How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News

How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News

Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies - Il Sole 24 ORE

Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies Il Sole 24 ORE

GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication - NAVLIN DAILY

GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication NAVLIN DAILY

Corrigendum to Transcriptomic landscape of coexisting ovarian clear cell carcinoma and endometriosis: Insights into malignant transformation .

Safety, Pharmacokinetics, and Sex Hormone Suppression of LY01021 versus Relugolix: A Single- and Multiple-Dose Escalation Study.

LY01021 is a novel oral small-molecule gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of various sex hormone-dependent disorders. This study aimed to evaluate the safety, tolerability, pharmacokinetics (PK), …